Temasek leads $50m Series B in digital health firm PEAR Therapeutics, EDBI joins round

Temasek leads $50m Series B in digital health firm PEAR Therapeutics, EDBI joins round

A Temasek Holdings Pte employee walks past the company's signage in their office in Singapore. Photographer: Munshi Ahmed/Bloomberg

Juliet Shwe Gaung

03 January, 2018

5AM Ventures Arboretum Ventures AZZ Venture Partners Bridge Builder’s Collaborative edbi JAZZ Venture Partners Novartis PEAR Therapeutics Temasek the Bridge Builder’s collaborative

Printed by Unregistered user on Wed, 10 Dec 2025 13:31:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Singapore

GIC’s sale of private equity fund portfolio could amass $3b: Report

Singapore’s Olam Group unit secures $1.12b dual currency loan